| Assembly of microarrays for genome-wide measurement of DNA copy number AM Snijders, N Nowak, R Segraves, S Blackwood, N Brown, J Conroy, ... Nature genetics 29 (3), 263-264, 2001 | 1235 | 2001 |
| Integration of cytogenetic landmarks into the draft sequence of the human genome T BAC Resource Consortium, VG Cheung, N Nowak, W Jang, IR Kirsch, ... Nature 409 (6822), 953-958, 2001 | 380 | 2001 |
| Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder SL Christian, CW Brune, J Sudi, RA Kumar, S Liu, S Karamohamed, ... Biological psychiatry 63 (12), 1111-1117, 2008 | 368 | 2008 |
| Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators L Wei, J Wang, E Lampert, S Schlanger, AD DePriest, Q Hu, EC Gomez, ... European urology 71 (2), 183-192, 2017 | 228 | 2017 |
| Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities Z Li, T Yu, M Morishima, A Pao, J LaDuca, J Conroy, N Nowak, SI Matsui, ... Human molecular genetics 16 (11), 1359-1366, 2007 | 209 | 2007 |
| Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology IW Deveson, B Gong, K Lai, JS LoCoco, TA Richmond, J Schageman, ... Nature biotechnology 39 (9), 1115-1128, 2021 | 148 | 2021 |
| Genome-wide aberrations in pancreatic adenocarcinoma NJ Nowak, D Gaile, JM Conroy, D McQuaid, J Cowell, R Carter, ... Cancer genetics and cytogenetics 161 (1), 36-50, 2005 | 134 | 2005 |
| Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden C Morrison, S Pabla, JM Conroy, MK Nesline, ST Glenn, D Dressman, ... Journal for immunotherapy of cancer 6, 1-12, 2018 | 132 | 2018 |
| Clinical spectrum and molecular diagnosis of Angelman and Prader‐Willi syndrome patients with an imprinting mutation S Saitoh, K Buiting, SB Cassidy, JM Conroy, DJ Driscoll, JM Gabriel, ... American journal of medical genetics 68 (2), 195-206, 1997 | 127 | 1997 |
| Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer CD Morrison, P Liu, A Woloszynska-Read, J Zhang, W Luo, M Qin, ... Proceedings of the National Academy of Sciences 111 (6), E672-E681, 2014 | 117 | 2014 |
| Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome LA Christ, CA Crowe, MA Micale, JM Conroy, S Schwartz The American Journal of Human Genetics 65 (5), 1387-1395, 1999 | 103 | 1999 |
| Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project DM Vega, LM Yee, LM McShane, PM Williams, L Chen, T Vilimas, ... Annals of Oncology 32 (12), 1626-1636, 2021 | 96 | 2021 |
| Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors JM Conroy, S Pabla, MK Nesline, ST Glenn, A Papanicolau-Sengos, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 92 | 2019 |
| Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region A Ronan, K Fagan, L Christie, J Conroy, NJ Nowak, G Turner Journal of medical genetics 44 (7), 448-451, 2007 | 92 | 2007 |
| Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol I Chung, AR Karpf, JR Muindi, JM Conroy, NJ Nowak, CS Johnson, ... Journal of biological chemistry 282 (12), 8704-8714, 2007 | 88 | 2007 |
| Indoleamine 2, 3-dioxygenase (IDO) inhibitors and cancer immunotherapy Y Fujiwara, S Kato, MK Nesline, JM Conroy, P DePietro, S Pabla, ... Cancer treatment reviews 110, 102461, 2022 | 87 | 2022 |
| Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms L Ali, T Helm, R Cheney, J Conroy, S Sait, J Guitart, P Gerami International journal of clinical and experimental pathology 3 (6), 593, 2010 | 83 | 2010 |
| Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients S Pabla, JM Conroy, MK Nesline, ST Glenn, A Papanicolau-Sengos, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 82 | 2019 |
| Complex patterns of copy number variation at sites of segmental duplications: an important category of structural variation in the human genome V Goidts, DN Cooper, L Armengol, W Schempp, J Conroy, X Estivill, ... Human genetics 120, 270-284, 2006 | 82 | 2006 |
| Mapping segmental and sequence variations among laboratory mice using BAC array CGH AM Snijders, NJ Nowak, B Huey, J Fridlyand, S Law, J Conroy, ... Genome research 15 (2), 302-311, 2005 | 79 | 2005 |
